Thoroughbred Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-637	Closed	-$308K	–	707
2025 Q1	$308K	Buy	637 +1	+0.2%	+$484	0.02%	537
2024 Q4	$256K	Buy	+636	New	+$256K	0.02%	587